previous  ...234567891011...  next  · entire list

A Life Saver Called "Plumpynut"
2007-10-21, CBS News
http://www.cbsnews.com/stories/2007/10/19/60minutes/main3386661.shtml

Every year, malnutrition kills five million children -- that's one child every six seconds. But now, the Nobel Prize-winning relief group "Doctors Without Borders" says it finally has something that can save millions of these children. It's cheap, easy to make and even easier to use. What is this miraculous cure? It's a ready-to-eat, vitamin-enriched concoction called "Plumpynut," an unusual name for a food that may just be the most important advance ever to cure and prevent malnutrition. "It's a revolution in nutritional affairs," says Dr. Milton Tectonidis, the chief nutritionist for Doctors Without Borders. "Now we have something. It is like an essential medicine. In three weeks, we can cure a kid that ... looked like they're half dead. It’s just, boom! It's a spectacular response," Dr. Tectonidis says. No kids need it more than ... in Niger, a desperately poor country in West Africa, where child malnutrition is so widespread that most mothers have watched at least one of their children die. Why are so many kids dying? Because they can't get the milk, vitamins and minerals their young bodies need. Mothers in these villages can't produce enough milk themselves and can't afford to buy it. Even if they could, they can't store it -- there’s no electricity, so no refrigeration. Powdered milk is useless because most villagers don't have clean water. Plumpynut was designed to overcome all these obstacles. Plumpynut is a remarkably simple concoction: it is basically made of peanut butter, powdered milk, powdered sugar, and enriched with vitamins and minerals. It tastes like a peanut butter paste. It is very sweet, and because of that kids cannot get enough of it. The formula was developed by a nutritionist. It doesn't need refrigeration, water, or cooking; mothers simply squeeze out the paste. Many children can even feed themselves. Each serving is the equivalent of a glass of milk and a multivitamin.

Drug Co. To Pay $515M Over Marketing
2007-09-28, CBS News
http://www.cbsnews.com/stories/2007/09/28/business/main3310529.shtml

Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing and pricing practices. The civil settlement ... resolves a broad array of allegations against Bristol-Myers Squibb, dating from 1994 through 2005. Among them was a charge that the ... company illegally promoted the sale of Abilify, an anti-psychotic drug, for pediatric use and to treat dementia-related psychoses. Neither use is approved by the U.S. [FDA]. Although physicians are permitted to prescribe drugs for off-label uses, drug companies are prohibited from marketing them for uses that have not been approved by the FDA. U.S. Attorney Michael Sullivan said when pharmaceutical companies market drugs for unapproved uses, there is a potential risk that patients could be harmed, because the drugs have not been tested as rigorously as they are during the FDA approval process. The government also alleged the company paid illegal inducements in the form of consulting fees and trips to luxury resorts to influence doctors and other health care providers to buy and prescribe the company's drugs. The company's former generic drug subsidiary, Apothecon Inc., also was accused of giving illegal enticements to induce retail pharmacy and wholesale customers to buy its products. Bristol-Myers Squibb misreported its best price for the anti-depression drug Serzone, violating a law that requires drug companies to report their lowest price to Medicaid, prosecutors said. The company was selling Serzone to a larger commercial purchaser at a lower price, prosecutors said. Bristol-Myers Squibb and Apothecon also inflated prices for an assortment of oncology and generic drugs knowing that federal health care programs established reimbursement rates based on those prices, Sullivan said.

Note: For lots more on corporate corruption, click here.

Diagnosis: Conflict of Interest
2007-06-13, New York Times
http://www.nytimes.com/2007/06/13/opinion/13carlat.html?ex=1339387200&en=68ba...

The revelation that the diabetes drug Avandia can potentially cause heart disease is the latest in a string of pharmaceutical disappointments. Vioxx was pulled from the market in 2004 because it doubled the risks for heart attacks and strokes. Eli Lilly recently paid $750 million to settle lawsuits alleging that Zyprexa causes diabetes. Many have criticized the Food and Drug Administration as being too lax about monitoring drug safety. While those criticisms have merit, there is another culprit: the transformation of continuing medical education into an enterprise for drug marketing. The chore of teaching doctors how to practice medicine has been handed to the pharmaceutical industry. As a result, dangerous side effects are rarely on the curriculum. Most states require that doctors obtain a minimum number of credit hours of continuing medical education each year to maintain their medical licenses. Not so long ago, most of these courses were produced and paid for by universities and medical associations. But this has changed drastically over the past decade. Drug-industry financing of continuing medical education has nearly quadrupled since 1998, from $302 million to $1.12 billion. Half of all continuing medical education courses in the United States are now paid for by drug companies, up from a third a decade ago. Because pharmaceutical companies now set much of the agenda for what doctors learn about drugs, crucial information about potential drug dangers is played down, to the detriment of patient care. For example, GlaxoSmithKline footed the bill for dozens of educational courses intended to emphasize the benefits of Avandia over other drugs.

Note: For a concise, reliable overview of medical corruption, click here.

Former Marine Claims Illness From Mystery Vaccine
2007-05-07, WLWT-TV (Cincinnati, Ohio's NBC affiliate)
http://www.wlwt.com/news/13271378/detail.html

An alarming number of U.S. troops are having severe reactions to some of the vaccines they receive in preparation for going overseas. "This is the worst cover-up in the history of the military," said an unidentified military health officer who fears for his job. A shot from a syringe is leaving some U.S. servicemen and women on the brink of death. Lance Corporal David Fey, 20, has dialysis three days a week. His kidneys are failing, his military career is over, and he feels like his country abandoned him. Fey said he loved every minute of boot camp and combat training at 29 Palms in California. But on Nov. 28, 2005, his life would change forever. Fey was one of a group of Marines who lined up for an undisclosed shot. "They asked us our name. We stood on these yellow footprints, and they gave us this shot, and we got the rest of the day off," he recalled. "After that shot, I started swelling up. I gained 30 pounds of water. My eyes swelled up where I couldn't see. I started snoring. I developed a rash on my hand." Three weeks later, Fey was back in Clermont County on his death bed at Clinton Memorial Hospital. His kidneys were failing, and his body was so swollen that it left stretch marks. Fey is one of a growing number of U.S. servicemen and women who are getting sick after receiving vaccines. And the ... Department of Defense medical officer who spoke with [WLWT] said that the number is up in the thousands. The symptoms range from joint aches and pains and arthritic symptoms to death. The officer said those who have claimed to have had adverse reactions to shots are treated like it is all in their heads. Asked whether servicemen and women are receiving experimental vaccines, the officer said, "I would hope to God not. But from what I've seen, I would have to say yes."

Doctors' Ties to Drug Companies Called Commonplace
2007-04-25, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2007/04/25/AR20070425022...

The ties between doctors and drug manufacturers are close indeed. Most physicians (94 percent) reported some type of relationship with the pharmaceutical industry ... according to [a] study, published in the April 26 issue of the New England Journal of Medicine. Most of these relationships involved receiving food in the workplace (83 percent) or receiving drug samples (78 percent). More than one-third of the respondents (35 percent) were reimbursed for costs associated with professional meetings or continuing medical education, while more than one-quarter (28 percent) were paid for consulting, delivering lectures or enrolling patients in clinical trials. Over the past two decades, physician-industry relationships have attracted increasing scrutiny. One review found that, on average, physicians meet with industry representatives four times a month, and medical residents accept six gifts annually from industry representatives. "We know that these relationships have benefits and risks, and we know that they benefit the companies that are involved, and we know from our data that they benefit doctors," said study author Eric G. Campbell, an assistant professor of health care policy at the Institute for Health Policy at Harvard Medical School. "The real question is to what extent do these relationships benefit patients, and the answer is, we don't know." Campbell said that he found it hard to believe that free football tickets for a doctor would trickle down to benefit patients.

Note: For an excellent article by one of the foremost doctors in the nation on how the pharmaceutical industry has corrupted politics and damaged our health, click here.

F.D.A. Warns of Sleeping Pills’ Strange Effects
2007-03-15, New York Times
http://www.nytimes.com/2007/03/15/business/15drug.ready.html?ex=1331611200&en...

The most widely prescribed sleeping pills can cause strange behavior like driving and eating while asleep, the Food and Drug Administration said yesterday, announcing that strong new warnings will be placed on the labels of 13 drugs. Use of those medications and other similar drugs has soared by more than 60 percent since 2000, fueled by television, print and other advertising. Last year, makers of sleeping pills spent more than $600 million on advertising aimed at consumers. Sales in the United States of Ambien and Lunesta alone last year exceeded $3 billion. Last year ... some users of the most widely prescribed drug, Ambien, started complaining online and to their doctors about unusual reactions ranging from fairly benign sleepwalking episodes to hallucinations, violent outbursts, nocturnal binge eating and — most troubling of all — driving while asleep. Sleep-drivers reported frightening episodes in which they recalled going to bed, but woke up to find they had been arrested roadside in their underwear or nightclothes. The agency also received reports of people making phone calls, purchasing items over the Internet, or having sex under the influence of sleep medication. In each case the consumers had no recollection of the events, which they said had occurred after they took their pills and headed for bed. "Hopefully this will make doctors think twice before blindly giving patients a prescription," said Dr. Mahowald. He also criticized marketing of the products. "I personally think the extent of advertising has just been unconscionable," he said.

Note: A reliable insider told us of a harrowing story where his company and the FDA made a secret agreement not to report numerous deaths resulting from one test drug so that it would pass and bring major profits. For lots more reliable, verifiable information on major corruption in the drug companies affecting your health, click here.

Texas Governor Defends Vaccine Order
2007-02-22, MSNBC/Associated Press
http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=AP&Date=2...

Gov. Rick Perry on Thursday angrily defended his relationship with Merck & Co. and his executive order requiring that schoolgirls receive the drugmaker's vaccine against the sexually transmitted cervical-cancer virus. The Associated Press reported Wednesday that Perry's chief of staff had met with key aides about the vaccine on Oct. 16, the same day Merck's political action committee donated $5,000 to the governor's campaign. In issuing the order, the governor made Texas the first state to require the vaccine Gardasil for all schoolgirls. But many lawmakers have complained about his bypassing the Legislature altogether. The executive order has inflamed conservatives, who said it contradicts Texas' abstinence-only sexual education policies and intrudes into families' lives. Critics have previously questioned Perry's ties to Merck. Mike Toomey, Perry's former chief of staff, now lobbies for the drug company. And the governor accepted a total of $6,000 from Merck during his re-election campaign. Merck has waged a behind-the-scenes lobbying campaign to get state legislatures to require girls to get the three-dose vaccine to enroll in school. But on Tuesday the pharmaceutical company announced it was suspending the effort because of pressure from parents and medical groups. The Kentucky House on Thurday passed a bill that would require the vaccination for middle school girls unless their parents sign a form opposing it. Virginia lawmakers have also passed legislation requiring the vaccine, but the governor has not decided if he will sign it.

Note: The drug company lobby is the most powerful in the U.S., as reported by the former editor-in-chief of one of the most respected medical journals in the U.S. Click here for more.

Journals 'regularly publish fraudulent research
2006-05-03, The Guardian (One of the U.K.'s leading newspapers)
http://society.guardian.co.uk/health/story/0,,1766642,00.html

Fraudulent research regularly appears in the 30,000 scientific journals published worldwide, a former editor of the British Medical Journal (BMJ) said today. Even when journals discover that published research is fabricated or falsified they rarely retract the findings, according to Richard Smith, who was also chief executive of the BMJ publishing group. Writing in the latest edition of the Journal of the Royal Society of Medicine, Dr Smith called on editors to blow the whistle on bad research and to use their clout to pressure universities into taking action against dodgy researchers. The former BMJ editor said it was likely that research fraud was "equally common" in the 30,000 plus scientific journals across the globe but was "invariably covered up". His call for action comes in the wake of several high profile cases of fraudulent research, including the Korean scientist Hwang Woo-suk who fabricated stem cell research that it was claimed would open up new ways to treat diseases like Parkinson's. Dr Smith criticised the failure of scientific institutions, including universities, to discipline dodgy researchers even when alerted to problems by journals. "Few countries have measures in place to ensure research is carried out ethically," he said. "Most cases are not publicised. They are simply not recognised, covered up altogether or the guilty researcher is urged to retrain, move to another institution or retire from research."

Note: For reliable information on the collusion of industry, government, and research facilities who place profits above advances in public health: http://www.WantToKnow.info/healthcoverup

Exposed: the secret corporate funding behind health research
2006-02-07, The Guardian (One of the UK's leading newspapers)
http://www.guardian.co.uk/comment/story/0,,1703694,00.html

Academics and the media have failed dismally to ask the crucial question of scientists' claims: who is paying you? In the 1990s...[Arise] was one of the world's most influential public-health groups. It described itself as "a worldwide association of eminent scientists who act as independent commentators". Its purpose...was to show how "everyday pleasures, such as eating chocolate, smoking, drinking tea, coffee and alcohol, contribute to the quality of life". "Scientific studies show that enjoying the simple pleasures in life, without feeling guilty, can reduce stress and increase resistance to disease". Between September 1993 and March 1994,...[Arise] generated 195 newspaper articles and radio and television interviews, in places such as the Wall Street Journal, the International Herald Tribune, the Independent, the Evening Standard, El País, La Repubblica, Rai and the BBC. In 1998...[tobacco] firms were obliged to place their internal documents in a public archive. Among them...is a memo from...Philip Morris - the world's largest tobacco company. The title is "Arise 1994-95 Activities and Funding". This showed that in the previous financial year Arise had received $373,400: ...over 99% - from Philip Morris, British American Tobacco, RJ Reynolds and Rothmans. The memo suggests Arise was run not by eminent scientists but by eminent tobacco companies. How much more science is being published in academic journals with undeclared interests like these? How many more media campaigns...have been secretly funded and steered by corporations?

Note: If you want to understand how corporate interests secretly manipulate both scientific results and public perception, this excellent article is well worth reading.

GM: New study shows unborn babies could be harmed
2006-01-06, Independent (One of the U.K.'s leading newspapers)
http://news.independent.co.uk/environment/article337253.ece

Women who eat GM [genetically modified] foods while pregnant risk endangering their unborn babies, startling new research suggests. The study...found that more than half of the offspring of rats fed on modified soya died in the first three weeks of life, six times as many as those born to mothers with normal diets. Six times as many were also severely underweight. The research - which is being prepared for publication - is just one of a clutch of recent studies that are reviving fears that GM food damages human health. Italian research has found that modified soya affected the liver and pancreas of mice. Australia had to abandon a decade-long attempt to develop modified peas when an official study found they caused lung damage. The World Trade Organisation is expected next month to support a bid by the Bush administration to force European countries to accept GM foods. The Monsanto soya is widely eaten by Americans.

Note: Though the European press provides good coverage, the US media is amazingly quiet on the issue of GMOs, which is so vital to our health. For an excellent overview: http://www.wanttoknow.info/deception10pg

Bird Flu Victims Die...After Becoming Resistant to Tamiflu
2005-12-22, ABC/Associated Press
http://abcnews.go.com/Health/wireStory?id=1430251

In a development health experts are calling alarming, two bird flu patients in Vietnam died after developing resistance to Tamiflu, the key drug that governments are stockpiling in case of a large-scale outbreak. The experts said the deaths were disturbing because the two girls had received early and aggressive treatment with Tamiflu and had gotten the recommended doses. Since 2003, avian flu has killed about 70 people, mostly in Vietnam and Thailand, and nearly all involved close contact with infected birds. Health experts fear the virus could morph into a form that spreads easily between people. The new report involved eight Vietnamese bird flu patients given Tamiflu upon being hospitalized in 2004 or 2005. Half of the patients died. Lab tests showed two of those who died...had developed resistance.

Note: If the above link fails, click here.

DuPont Stuck With Big Teflon Fine
2005-12-14, CBS/Associated Press
http://www.cbsnews.com/stories/2005/12/14/business/main1124537.shtml

DuPont Co. has agreed to pay $10.25 million in fines and $6.25 million for environmental projects in a settlement with the Environmental Protection Agency over the company's alleged failure to report the dangers of a toxic chemical used to make Teflon. EPA officials said the settlement represents the largest civil administrative penalty the agency has ever obtained under any federal environmental statute. The EPA alleged that DuPont withheld information for more than 20 years about the health effects of PFOA. DuPont faced a potential fine of more than $300 million for not reporting that the chemical posed a substantial risk of injury to health or the environment. "The settlement allows us to put this matter behind us and move forward," said [DuPont general counsel Stacey] Mobley, who noted that the company has cut PFOA emissions from U.S. plant sites by 98 percent and hopes to reduce emissions even further by 2007. DuPont...still faces a federal criminal investigation of its actions concerning PFOA. In a draft report released in June, the majority of members on a scientific advisory board that reviewed the EPA's draft risk assessment concluded that the chemical is "likely" to be carcinogenic to humans.

Bush lifts wage rules for Katrina
2005-09-09, CNN/Reuters
http://money.cnn.com/2005/09/08/news/economy/katrina_wages.reut

President Bush issued an executive order Thursday allowing federal contractors rebuilding in the aftermath of Hurricane Katrina to pay below the prevailing wage. In a notice to Congress, Bush said the hurricane had caused "a national emergency" that permits him to take such action. Bush's action came as the federal government moved to provide billions of dollars in aid. The administration is using the devastation of Hurricane Katrina to cut the wages of people desperately trying to rebuild their lives and their communities.

Merck CEO Resigns as Drug Probe Continues
2005-05-06, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2005/05/05/AR20050505011...

Merck & Co.'s longtime leader Raymond V. Gilmartin abruptly resigned yesterday on the same day congressional investigators released a slew of documents detailing how the company continued to aggressively promote its arthritis drug Vioxx after it knew of potentially serious safety concerns. The documents...showed that Merck directed its 3,000-person Vioxx sales force to avoid discussions with doctors about the cardiovascular risks identified in a major clinical trial of the drug in 2000. Sales representatives were told instead to rely on a "Cardiovascular Card" that said Vioxx was protecting the heart rather than potentially harming it. They were [also] trained how to smile, speak and position themselves most effectively when talking with doctors, and were exhorted to sell Vioxx and other Merck drugs using the Rev. Martin Luther King Jr.'s "I Have a Dream" speech. Vioxx was withdrawn from the market last September after another clinical trial found that people who had taken the drug for 18 months were five times more likely to have heart attacks and strokes than those on a placebo. Merck was sharply criticized in a hearing into how the company and the Food and Drug Administration had handled the safety concerns surrounding Vioxx.

EPA Mercury Rule Omits Conflicting Data
2005-03-22, Washington Post
http://www.washingtonpost.com/wp-dyn/articles/A55268-2005Mar21.html

When the Environmental Protection Agency unveiled a rule last week to limit mercury emissions from U.S. power plants, officials emphasized that the controls could not be more aggressive because the cost to industry already far exceeded the public health payoff. What they did not reveal is that a Harvard University study paid for by the EPA, co-authored by an EPA scientist and peer-reviewed by two other EPA scientists had reached the opposite conclusion. That analysis estimated health benefits 100 times as great as the EPA did, but top agency officials ordered the finding stripped from public documents.

Silver Bullet: Depleted Uranium
2000-02-07, CBC (Canadian Broadcasting Corporation - Canada's PBS)
http://web.archive.org/web/20000903222100/http://www.tv.cbc.ca/national/pgmin...

Jerry Wheat and the other Gulf vets were never told of the risks of being exposed to a DU campaign. Awarded a Purple Heart after being wounded in combat, Wheat came home with pieces of shrapnel embedded in his body and with mysterious body pains. A year after war's end, Wheat got startling evidence from his father -- a technician at the famous Los Alamos Nuclear Research Centre, who just out of curiosity tested the shrapnel that came from his son's body and gear. The shrapnel was radioactive. Today, eight years after the Gulf War, that shrapnel still lights up a Geiger counter. Jerry's great fear is that whatever he brought back with him from the Gulf is now afflicting his family. His older son Joe was hospitalized with breathing problems the day after Wheat dragged his contaminated gear into the house. Derrick, his youngest son, who was born after the war, suffers strange blisters on his hands. His wife suffered a miscarriage. Jerry himself recently had a tumour removed from his shoulder. He now worries continually about cancer. Jerry says the military has never shown any interest in his shrapnel. The military said Jerry's health problems are due to post traumatic stress. If the lessons from past eras are anything to go by, there is often great ignorance about the path being charted when new weapons come along. For example when atomic testing was all the rage in the '50s, or when Agent Orange was used in Vietnam. When revolutionary new technology is introduced on the battlefield, no one at the time has any real idea of the consequences.

Note: BBC has a webpage listing 10 of their articles both pro and con regarding depleted uranium at http://news.bbc.co.uk/2/hi/in_depth/europe/2001/depleted_uranium/default.stm

California medical schools earn A's in conflict grading
2008-06-04, San Francisco Chronicle (San Francisco's leading newspaper
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/06/04/BUV3112O9V.DTL

Drug companies shower medical school faculty members with pens, pricey dinners, free samples and other inducements to influence their prescribing patterns, an organization of U.S. medical students says. The med students are now trying to erase that pattern by grading their teachers. The American Medical Student Association issued its second annual report card ... on the conflict-of-interest policies maintained at 150 universities that grant a medical degree. California dominated the honor roll. UC Davis, UCSF and UCLA captured three of the seven A grades across the country. But only 15 percent of U.S. medical schools made the top of the class with a grade of A or B, based on their adoption of rules such as barring drug companies from distributing lavish gifts to physicians. Sixty of the schools, or 40 percent, got an F on the student association's 2008 PharmFree Scorecard. The American Medical Student Association started its PharmFree campaign in 2002 after members shared their concerns about interactions they observed between their medical professors and drug industry representatives. The Association of American Medical Colleges in April proposed that all med schools adopt policies to prevent drug marketing efforts from distorting the educational environment. The proposed rules would restrict industry funding of seminars, forbid companies from selecting the recipients of scholarships they fund and strongly discourage medical school faculty members from participating in industry-sponsored speakers' bureaus.

Note: For a treasure trove of important reports on health issues from reliable sources, click here.

Nanoparticles scrutinized for health effects
2008-05-12, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/05/12/BU4P10BB88.DTL

Windows cleaned by raindrops, white sofas immune to red wine spills, tiles protected from limescale buildup -- new products created from minute substances called nanoparticles are making such domestic dreams come true. Based on tiny particles 10,000 times thinner than a strand of hair, ... nanoparticles are showing up in everything from fabric coatings to socks to plush teddy bears. But some scientists are concerned that these seemingly magical materials are hitting the market before their effects on human health and the environment have been sufficiently studied. The few scientific reports available suggest that nanoparticles can pose a threat to human health and to the environment. For example, fish swimming in water containing modest amounts of fullerenes, soccer-ball-shaped nanoparticles made out of 60 carbon atoms, showed a large increase in brain damage. These are the same types of fullerenes being used in various skin products. From the skin, they can travel through the lymphatic duct system to lymph nodes and eventually end up in organs such as the liver, kidney and spleen. When inhaled, nanoparticles will go deeper into the lungs than larger particles and reach more sensitive parts. Because of that, scientists are particularly concerned about nanoparticles being used in spray products. "We have research showing that as a material shrinks in size, it becomes more harmful to the lungs. Nanoparticles tend to be more inflammatory to the lung, and it seems as if the lung has to work harder to get rid of them," said Andrew Maynard, chief science adviser at the Project on Emerging Nanotechnologies in Washington.

Note: For a treasure trove of health reports from major media, click here.

FDA warns Merck to fix vaccine plant problems
2008-04-30, San Francisco Chronicle/Associated Press
http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2008/04/30/financial/f084419...

The Food and Drug Administration has ordered Merck & Co. to correct numerous manufacturing deficiencies at its main vaccine plant. The agency ... released a warning letter sent to Merck's chief executive, Richard T. Clark, that states FDA inspectors determined manufacturing rules are not being followed at the plant in West Point, Pa., just outside Philadelphia. The plant, which recalled two vaccines in December over sterility problems, makes a number of children's vaccines and four for adults. The nine-page letter states FDA found "significant objectionable conditions" in the manufacture of vaccines and drug ingredients during repeated inspections from Nov. 26 to Jan. 17. According to the heavily redacted warning letter, Merck officials didn't thoroughly investigate when vaccine batches inexplicably failed to meet specifications, even if batches had been distributed, and some combination measles-mumps-rubella shots that failed "visual inspection for critical defects" were distributed anyway. Production of two vaccines made at West Point — PedvaxHIB, to prevent Haemophilus influenza type B, and Comvax, a combination vaccine for Haemophilus B and hepatitis B — stopped last year and 1.2 million doses of them were recalled after a sterility problem was discovered in October. The plant also makes ProQuad, which protects children against measles, mumps, rubella and chickenpox; hepatitis A, hepatitis B and meningitis vaccines for children and adults; and Gardasil, to protect young women against cervical cancer.

Note: For further revelations from reliable sources on the dangers of vaccines, click here.

Practicing Patients
2008-03-23, New York Times
http://www.nytimes.com/2008/03/23/magazine/23patients-t.html?ex=1363924800&en...

Todd Small was stuck in quicksand again. His brain was sending an electrical pulse saying “walk,” but as the signal streaked from his cerebellum and down his spinal cord, it snagged on scar tissue where the myelin layer insulating his nerve fibers had broken down. The message wasn’t getting to his hip flexors or his hamstrings or his left foot. That connection had been severed by his multiple sclerosis. And once again, Small was left with the feeling that, as he described it, “I’m up to my waist in quicksand.” Small would have continued just as he was had he not logged on last June to a Web site called PatientsLikeMe. He expected the sort of online community he’d tried and abandoned several times before — one abundant in sympathy and stories but thin on practical information. But he found something altogether different: data. There are a little more than 7,000 Todd Smalls at PatientsLikeMe, congregating around diseases like Parkinson’s, multiple sclerosis (M.S.) and AIDS, all of them contributing their experiences and tweaking their treatments. The members of PatientsLikeMe don’t just share their experiences anecdotally; they quantify them, breaking down their symptoms and treatments into hard data. They note what hurts, where and for how long. They list their drugs and dosages and score how well they alleviate their symptoms. All this gets compiled over time, aggregated and crunched into tidy bar graphs and progress curves by the software behind the site. And it’s all open for comparison and analysis. By telling so much, the members of PatientsLikeMe are creating a rich database of disease treatment and patient experience.

Note: For a treasure trove of revealing reports on health issues from reliable sources, click here.

previous

...234567891011...

next

· entire list